Christina Shafer

Chief Commercial Officer, Marinus Pharmaceuticals (United States).

Companies

Neurogene Inc.Chief Commercial Officer Apr 20, 2026 to now¹
Marinus Pharmaceuticals (United States)Chief Commercial Officer Jun 23, 2022 to Feb 11, 2025²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 11, 2025Returned to company 48,628 shares at $0.55 of Marinus Pharmaceuticals (United States)³
Feb 7, 2025Returned to company 18,778 shares at $0.55 of Marinus Pharmaceuticals (United States)³
Aug 5, 2024Sold 3,820 shares at $1.14 of Marinus Pharmaceuticals (United States)⁴
Jun 18, 2024Granted 10,918 shares of Marinus Pharmaceuticals (United States)⁵
Feb 20, 2024Sold 2,153 shares at $9.56 of Marinus Pharmaceuticals (United States)⁶
Jan 18, 2024Granted 21,835 shares of Marinus Pharmaceuticals (United States)⁷
Aug 8, 2023Sold 11 shares at $8.93 of Marinus Pharmaceuticals (United States)⁸
Aug 7, 2023Sold 2,385 shares at $9.52 of Marinus Pharmaceuticals (United States)⁸
Jan 26, 2023Granted 17,375 shares of Marinus Pharmaceuticals (United States)⁹
Nov 9, 2022Shares withheld for tax 1,505 shares at $4.70 of Marinus Pharmaceuticals (United States)¹⁰

The numbers on this page point here. Each one links to the record it came from.